Lv1
10 积分 2025-06-23 加入
Switching from insulin injections to degludec/liraglutide in older frail persons: 6-month body composition remodelling
10小时前
待确认
Once-Weekly Mazdutide in Obesity or Overweight
25天前
已完结
Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials
2个月前
已完结
Semaglutide in MASH: A Promising Step Forward with Room for Improvement
3个月前
已关闭
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes Mellitus
3个月前
已关闭
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose co‐transporter‐2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta‐analysis
3个月前
已完结
[Chinese guideline on the primary prevention of cardiovascular diseases in primary health care]
4个月前
已完结
[Chinese expert consensus on diagnosis and management of patients with cardiovascular diseases and cognitive impairment]
4个月前
已完结
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
4个月前
已完结
Prevalence of Chronic Kidney Disease in China
4个月前
已完结
皖公网安备34019202002308
